我公司的产品主要有三大系列：管制玻璃瓶，模制玻璃瓶和吸塑内托。管制玻璃瓶主要包括口服液瓶、西林瓶、注射剂瓶、安瓿瓶、螺纹口瓶、喷雾瓶、滴管瓶等。模制玻璃瓶主要包括钠钙玻璃药瓶、模制注射剂瓶、模制口服液瓶、输液瓶、广口瓶、保健品玻璃瓶、精油瓶、乳液瓶、膏霜瓶、香水瓶、指甲油瓶等。吸塑内托主要有口服液托盘，西林瓶托、水针托、食品内托、植绒托等。我公司三大产品适用于口服液、粉针制剂、水针制剂、冻干制剂、生物制剂、大输液、片剂、胶囊等不同药品制剂及食品、化妆品的包装需要。

我公司玻璃瓶深加工车间成立于2008年，拥有丰富的玻璃瓶深加工经验，可为客户提供烫金(烫银)、烤花、丝网印刷、蒙砂、UV印刷、镀膜、喷涂等工艺，使客户的产品包装更上一层楼。选择荣昌包装，您的产品就成功了一半。

荣昌公司年产各种玻璃瓶10亿支，塑料托盘10亿个。产品销往北京同仁堂、哈药集团、吉林敖东药业、修正集团等全国30多个省市的医药保健品行业，部分产品还远销菲律宾、巴基斯坦、古巴、印度尼西亚、韩国等国家或地区，受到用户的一致好评。

公司产品完全按照GMP医药标准生产，于2006年取得国家食品药品监督管理局颁发的《药品包装用材料和容器注册证》，并在2014年完成新药包材证书的换证工作。至此我公司已获得多个《药品包装用材料和容器注册证》，“钠钙玻璃管制口服液体瓶”：“国药包字20140436”；“低硼硅玻璃管制注射剂瓶”：“国药包字20140954”；“中性硼硅玻璃管制注射剂瓶”：“国药包字20140867”。

荣昌理念：勤奋、科学、开拓、创新、诚信、安全的企业方针，以市场为导向，以质量为生命，以优质服务为保障。靠科技、保质量、创品牌、增品种、创效益，竭诚为医疗事业，为人类健康奉献高精尖、高品质的医药包装。诚挚欢迎国内外客商光临指导，洽谈合作。

Cangzhou Rongchang Glasswork Co., Ltd. is a large production base certified by the SFDA, specializing in the production of medicinal glass bottles. The company is located in the state-level industrial development zone - Botou industrial zone Road No. 3. The plant situates in a beautiful environment,trees make a pleasant shade, it is an ideal venue for the production of medicinal bottles; it enjoys convenient transportation, 2 km close to the Beijing-Shanghai High-speed Railway, only 180 km away from the Tianjin Port. The company was founded in 1985, with registered capital of 5 million yuan, after nearly three decades of vigorous development, it has owned fixed assets of 80 million yuan, annual output value of 300 million yuan, covers an area of 66,000 square meters, standardized plant 15,000 square meters, now there are more than 500 employees, including 380 engineers and technicians. 

Rongchang company has annual output 1 billion of various bottles, 1 billion plastic trays. The products are sold to Beijing Tong Ren Tang, Harbin Pharmaceutical Group, Jilinaodong Medicine, Xiuzheng Pharmaceutical Group, pharmaceutical and health products industry in more than 30 provinces and cities nationwide, some products are also exported to Philippines, Pakistan, Cuba, Indonesia, South Korea and other countries or regions, they are greatly praised by users.